O. Kryštůfková

发表

Pro‐inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis

H. Mann, J. Vencovský, K. Pavelka, 2019, Cytokine.

Fever of unknown origin.

J. Gregorová, M. Gregová, M. Trojánek, 2021, Vnitrni lekarstvi.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

May Y. Choi, A. Mammen, P. van Damme, 2016, Autoimmunity reviews.

Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study

H. Mann, J. Vencovský, K. Pavelka, 2019, Rheumatology International.

The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy.

J. Vencovský, K. Pavelka, S. Gay, 2011, Cytokine.

Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.

T. Svitálková, L. Pleštilová, H. Mann, 2017, Clinical and experimental rheumatology.

Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.

M. Bottai, R. Zubarev, L. Padyukov, 2015, The Journal of clinical investigation.

Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.

J. Vencovský, F. V. D. van den Hoogen, A. Boots, 2007, Arthritis and rheumatism.

Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies

J. Vencovský, I. Lundberg, V. Malmström, 2014, Arthritis Research & Therapy.

Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis

J. Vencovský, K. Pavelka, L. Šenolt, 2011, Annals of the Rheumatic Diseases.

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

J. Lamb, H. Nagaraja, A. Payton, 2022, Annals of the Rheumatic Diseases.

Interleukin-35 in idiopathic inflammatory myopathies.

H. Mann, J. Vencovský, J. Zamecnik, 2020, Cytokine.

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies

H. Mann, J. Vencovský, I. Lundberg, 2008, Annals of the rheumatic diseases.

, inflammatory myopathies ( BAFF ) in subsets of patients with idiopathic Increased serum levels of B cell activating factor

H. Mann, J. Vencovský, I. Lundberg, 2009 .

The significance of antibodies to cyclic citrullinated peptide, antikeratin antibodies, anti-perinuclear factor, rheumatoid factor isotypes and HLA shared epitope in prediction of erosive disease in early rheumatoid arthritis patients

J. Vencovský, V. Pešáková, O. Kryštůfková, 2001, Arthritis Research.

Abstracts of the 21st European Workshop for Rheumatology

J. Vencovský, V. Pešáková, O. Kryštůfková, 2001 .

Serum levels of interferon α do not correlate with disease activity in patients with dermatomyositis/polymyositis

H. Mann, J. Vencovský, O. Beran, 2010, Annals of the rheumatic diseases.

Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.

H. Mann, J. Vencovský, J. Ukropec, 2020, Rheumatology.

No Evidence for Linkage between the Hereditary Angiooedema Clinical Phenotype and the BDKR1, BDKR2, ACE or MBL2 gene

J. Litzman, B. Ravčuková, Jirí Jarkovský, 2011, Scandinavian journal of immunology.

Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema.

J. Litzman, L. Kolářová, T. Freiberger, 2002, Human immunology.

[Essential mixed cryoglobulinemia and the kidneys].

O. Kryštůfková, V. Knotková, 1993, Vnitrni lekarstvi.

The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis.

H. Mann, J. Vencovský, K. Pavelka, 2020, Rheumatology.

Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis

H. Mann, J. Vencovský, I. Lundberg, 2018, Arthritis Research & Therapy.

Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study

H. Mann, J. Vencovský, K. Pavelka, 2022, Frontiers in Immunology.

Effect of CTLA4‐Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis

D. Ramsköld, H. Mann, J. Vencovský, 2018, Scandinavian journal of immunology.

[Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].

V. Tesar, O. Kryštůfková, I. Janatková, 1995, Bratislavske lekarske listy.

Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile.

H. Mann, J. Vencovský, J. Ukropec, 2020, Clinical and experimental rheumatology.

[Fever of unknown origin].

I. Marie, H. Lévesque, A. Sanson, 2008, La Revue de medecine interne.

High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis

J. Vencovský, K. Pavelka, L. Šenolt, 2021, Scientific reports.

Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort

P. Kralickova, J. Litzman, B. Ravčuková, 2023, Journal of Clinical Immunology.

Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies

H. Mann, V. Leclair, A. Notarnicola, 2024, Seminars in Arthritis and Rheumatism.

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies

K. Lindblad-Toh, J. Lamb, A. Syvänen, 2023, EBioMedicine.

Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients.

H. Mann, J. Vencovský, J. Zamecnik, 2016, Clinical and experimental rheumatology.